Rigel Pharmaceuticals, Inc.
AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME
Last updated:
Abstract:
Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure ##STR00001## wherein E, J, T, the ring system denoted by "B", T, R.sup.3, R.sup.4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.
Status:
Application
Type:
Utility
Filling date:
25 Jun 2019
Issue date:
16 Jan 2020